Annual report
8095.TEDINET S100XN2T
Period2024-12-01 → 2025-11-30
Filed2026-02-25
StandardJapan GAAP
ConsolidatedYes
Data checks24 of 24 passed
Key figures · 151
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥62.7bn | 2024-12-01 → 2025-11-30 | Cons. | Net sales |
| Revenue | ¥58.0bn | 2023-12-01 → 2024-11-30 | Cons. | Net sales |
| Revenue | ¥52.0bn | 2022-12-01 → 2023-11-30v | Cons. | Net sales (5-year summary) |
| Revenue | ¥49.6bn | 2021-12-01 → 2022-11-30v | Cons. | Net sales (5-year summary) |
| Revenue | ¥72.3bn | 2020-12-01 → 2021-11-30d | Cons. | Net sales (5-year summary) |
| Operating income | ¥3.0bn | 2024-12-01 → 2025-11-30 | Cons. | Operating income |
| Operating income | ¥2.8bn | 2023-12-01 → 2024-11-30 | Cons. | Operating income |
| Ordinary income | ¥2.9bn | 2024-12-01 → 2025-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥2.8bn | 2023-12-01 → 2024-11-30 | Cons. | Ordinary income |
| Ordinary income | ¥1.4bn | 2022-12-01 → 2023-11-30v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥887m | 2021-12-01 → 2022-11-30v | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥2.4bn | 2020-12-01 → 2021-11-30d | Cons. | Ordinary income loss (5-year summary) |
| Profit before tax | ¥2.9bn | 2024-12-01 → 2025-11-30 | Cons. | Income before income taxes |
| Profit before tax | −¥1.5bn | 2023-12-01 → 2024-11-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥2.2bn | 2024-12-01 → 2025-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | −¥2.5bn | 2023-12-01 → 2024-11-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥1.2bn | 2022-12-01 → 2023-11-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥579m | 2021-12-01 → 2022-11-30v | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.7bn | 2020-12-01 → 2021-11-30d | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income | ¥2.2bn | 2024-12-01 → 2025-11-30 | Cons. | Profit loss |
| Net income | −¥2.5bn | 2023-12-01 → 2024-11-30 | Cons. | Profit loss |
| Total assets | ¥75.4bn | at 2025-11-30 | Cons. | Assets |
| Total assets | ¥64.6bn | at 2024-11-30 | Cons. | Assets |
| Total assets | ¥67.3bn | at 2023-11-30v | Cons. | Total assets (5-year summary) |
| Total assets | ¥63.6bn | at 2022-11-30v | Cons. | Total assets (5-year summary) |
| Total assets | ¥63.6bn | at 2021-11-30d | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥48.0bn | at 2025-11-30 | Cons. | Liabilities |
| Total liabilities | ¥39.3bn | at 2024-11-30 | Cons. | Liabilities |
| Net assets / equity | ¥27.4bn | at 2025-11-30 | Cons. | Net assets |
| Net assets / equity | ¥25.3bn | at 2024-11-30 | Cons. | Net assets |
| Net assets / equity | ¥28.6bn | at 2023-11-30v | Cons. | Net assets |
| Net assets / equity | ¥27.1bn | at 2022-11-30v | Cons. | Net assets (5-year summary) |
| Net assets / equity | ¥27.0bn | at 2021-11-30d | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥10.2bn | at 2025-11-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥6.1bn | at 2024-11-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥10.1bn | at 2025-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.0bn | at 2024-11-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2023-11-30v | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥6.8bn | at 2022-11-30v | Cons. | Cash and cash equivalents (5-year summary) |
| Cash & equivalents | ¥10.8bn | at 2021-11-30d | Cons. | Cash and cash equivalents (5-year summary) |
| Operating cash flow | ¥3.4bn | 2024-12-01 → 2025-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥4.8bn | 2023-12-01 → 2024-11-30 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥1.6bn | 2022-12-01 → 2023-11-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥742m | 2021-12-01 → 2022-11-30v | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥1.3bn | 2020-12-01 → 2021-11-30d | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Investing cash flow | −¥5.6bn | 2024-12-01 → 2025-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.9bn | 2023-12-01 → 2024-11-30 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥2.8bn | 2022-12-01 → 2023-11-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥2.2bn | 2021-12-01 → 2022-11-30v | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥4.4bn | 2020-12-01 → 2021-11-30d | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Financing cash flow | ¥6.2bn | 2024-12-01 → 2025-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥2.7bn | 2023-12-01 → 2024-11-30 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.1bn | 2022-12-01 → 2023-11-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥1.1bn | 2021-12-01 → 2022-11-30v | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥6.4bn | 2020-12-01 → 2021-11-30d | Cons. | Net cash provided by used in financing activities (5-year summary) |
| EPS (basic) | ¥54.23 | 2024-12-01 → 2025-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥-63.18 | 2023-12-01 → 2024-11-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥29.47 | 2022-12-01 → 2023-11-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥14.56 | 2021-12-01 → 2022-11-30v | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥46.86 | 2020-12-01 → 2021-11-30d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥46.63 | 2020-12-01 → 2021-11-30d | Cons. | Diluted earnings per share (5-year summary) |
| Net assets per share | ¥670.86 | at 2025-11-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥625.15 | at 2024-11-30 | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥719.53 | at 2023-11-30v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥685.24 | at 2022-11-30v | Cons. | Net assets per share (5-year summary) |
| Net assets per share | ¥677.09 | at 2021-11-30d | Cons. | Net assets per share (5-year summary) |
| Equity ratio | 35.9% | at 2025-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.0% | at 2024-11-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.3% | at 2023-11-30v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.5% | at 2022-11-30v | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 42.5% | at 2021-11-30d | Cons. | Equity to asset ratio (5-year summary) |
| ROE | 8.4% | 2024-12-01 → 2025-11-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | -9.4% | 2023-12-01 → 2024-11-30 | Cons. | Rate of return on equity (5-year summary) |
| ROE | 4.2% | 2022-12-01 → 2023-11-30v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 2.1% | 2021-12-01 → 2022-11-30v | Cons. | Rate of return on equity (5-year summary) |
| ROE | 7.1% | 2020-12-01 → 2021-11-30d | Cons. | Rate of return on equity (5-year summary) |
| Employees | 1,543 | at 2025-11-30 | Cons. | Number of employees |
| Employees | 1,420 | at 2024-11-30 | Cons. | Number of employees |
| Employees | 1,404 | at 2023-11-30v | Cons. | Number of employees |
| Employees | 1,383 | at 2022-11-30v | Cons. | Number of employees |
| Employees | 1,368 | at 2021-11-30d | Cons. | Number of employees |
| Revenue | ¥3.8bn | 2024-12-01 → 2025-11-30 | Standalone | Operating revenue1 |
| Revenue | ¥2.9bn | 2023-12-01 → 2024-11-30 | Standalone | Operating revenue1 |
| Revenue | ¥2.8bn | 2022-12-01 → 2023-11-30v | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥2.8bn | 2021-12-01 → 2022-11-30v | Standalone | Operating revenue1 (5-year summary) |
| Revenue | ¥23.0bn | 2020-12-01 → 2021-11-30d | Standalone | Net sales (5-year summary) |
| Revenue | ¥1.3bn | 2020-12-01 → 2021-11-30d | Standalone | Operating revenue1 (5-year summary) |
| Operating income | ¥693m | 2024-12-01 → 2025-11-30 | Standalone | Operating income |
| Operating income | ¥84m | 2023-12-01 → 2024-11-30 | Standalone | Operating income |
| Ordinary income | ¥181m | 2024-12-01 → 2025-11-30 | Standalone | Ordinary income |
| Ordinary income | −¥29m | 2023-12-01 → 2024-11-30 | Standalone | Ordinary income |
| Ordinary income | ¥209m | 2022-12-01 → 2023-11-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥290m | 2021-12-01 → 2022-11-30v | Standalone | Ordinary income loss (5-year summary) |
| Ordinary income | ¥304m | 2020-12-01 → 2021-11-30d | Standalone | Ordinary income loss (5-year summary) |
| Profit before tax | ¥406m | 2024-12-01 → 2025-11-30 | Standalone | Income before income taxes |
| Profit before tax | ¥214m | 2023-12-01 → 2024-11-30 | Standalone | Income before income taxes |
| Net income | ¥294m | 2024-12-01 → 2025-11-30 | Standalone | Profit loss |
| Net income | ¥92m | 2023-12-01 → 2024-11-30 | Standalone | Profit loss |
| Net income | ¥702m | 2022-12-01 → 2023-11-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥831m | 2021-12-01 → 2022-11-30v | Standalone | Net income loss (5-year summary) |
| Net income | ¥788m | 2020-12-01 → 2021-11-30d | Standalone | Net income loss (5-year summary) |
| Total assets | ¥37.5bn | at 2025-11-30 | Standalone | Assets |
| Total assets | ¥31.0bn | at 2024-11-30 | Standalone | Assets |
| Total assets | ¥32.7bn | at 2023-11-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥30.1bn | at 2022-11-30v | Standalone | Total assets (5-year summary) |
| Total assets | ¥30.2bn | at 2021-11-30d | Standalone | Total assets (5-year summary) |
| Total liabilities | ¥24.1bn | at 2025-11-30 | Standalone | Liabilities |
| Total liabilities | ¥17.3bn | at 2024-11-30 | Standalone | Liabilities |
| Net assets / equity | ¥13.4bn | at 2025-11-30 | Standalone | Net assets |
| Net assets / equity | ¥13.7bn | at 2024-11-30 | Standalone | Net assets |
| Net assets / equity | ¥14.6bn | at 2023-11-30v | Standalone | Net assets |
| Net assets / equity | ¥13.9bn | at 2022-11-30v | Standalone | Net assets (5-year summary) |
| Net assets / equity | ¥14.0bn | at 2021-11-30d | Standalone | Net assets (5-year summary) |
| Cash and deposits | ¥2.1bn | at 2025-11-30 | Standalone | Cash and deposits |
| Cash and deposits | ¥568m | at 2024-11-30 | Standalone | Cash and deposits |
| EPS (basic) | ¥7.29 | 2024-12-01 → 2025-11-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥2.32 | 2023-12-01 → 2024-11-30 | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥17.79 | 2022-12-01 → 2023-11-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥20.88 | 2021-12-01 → 2022-11-30v | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥21.27 | 2020-12-01 → 2021-11-30d | Standalone | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥21.16 | 2020-12-01 → 2021-11-30d | Standalone | Diluted earnings per share (5-year summary) |
| Dividend per share | ¥18 | 2024-12-01 → 2025-11-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥18 | 2023-12-01 → 2024-11-30 | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥18 | 2022-12-01 → 2023-11-30v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥18 | 2021-12-01 → 2022-11-30v | Standalone | Dividend paid per share (5-year summary) |
| Dividend per share | ¥18 | 2020-12-01 → 2021-11-30d | Standalone | Dividend paid per share (5-year summary) |
| Net assets per share | ¥331.29 | at 2025-11-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥340.64 | at 2024-11-30 | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥370.38 | at 2023-11-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥352.82 | at 2022-11-30v | Standalone | Net assets per share (5-year summary) |
| Net assets per share | ¥350.47 | at 2021-11-30d | Standalone | Net assets per share (5-year summary) |
| Equity ratio | 35.7% | at 2025-11-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.2% | at 2024-11-30 | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 44.8% | at 2023-11-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.2% | at 2022-11-30v | Standalone | Equity to asset ratio (5-year summary) |
| Equity ratio | 46.3% | at 2021-11-30d | Standalone | Equity to asset ratio (5-year summary) |
| ROE | 2.2% | 2024-12-01 → 2025-11-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 0.7% | 2023-12-01 → 2024-11-30 | Standalone | Rate of return on equity (5-year summary) |
| ROE | 4.9% | 2022-12-01 → 2023-11-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 6.0% | 2021-12-01 → 2022-11-30v | Standalone | Rate of return on equity (5-year summary) |
| ROE | 5.9% | 2020-12-01 → 2021-11-30d | Standalone | Rate of return on equity (5-year summary) |
| Shares issued | 41,097,566 | at 2025-11-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 40,982,832 | at 2024-11-30 | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 40,884,504 | at 2023-11-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 40,772,366 | at 2022-11-30v | Standalone | Total number of issued shares (5-year summary) |
| Shares issued | 40,630,087 | at 2021-11-30d | Standalone | Total number of issued shares (5-year summary) |
| Employees | 96 | at 2025-11-30 | Standalone | Number of employees |
| Employees | 95 | at 2024-11-30 | Standalone | Number of employees |
| Employees | 93 | at 2023-11-30v | Standalone | Number of employees |
| Employees | 105 | at 2022-11-30v | Standalone | Number of employees |
| Employees | 109 | at 2021-11-30d | Standalone | Number of employees |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 84
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2024-12-01 → 2025-11-30 | ¥0 |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | employees | at 2025-11-30 | 11 pure |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2024-12-01 → 2025-11-30 | ¥64m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2024-12-01 → 2025-11-30 | ¥57m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2024-12-01 → 2025-11-30 | ¥7m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2024-12-01 → 2025-11-30 | −¥363m |
| Reconciling Itemsreconciling | depreciation | 2024-12-01 → 2025-11-30 | ¥387m |
| Reconciling Itemsreconciling | revenue | 2024-12-01 → 2025-11-30 | −¥1.3bn |
| Reconciling Itemsreconciling | revenue intersegment | 2024-12-01 → 2025-11-30 | −¥1.3bn |
| Reconciling Itemsreconciling | segment profit | 2024-12-01 → 2025-11-30 | −¥80m |
| Fine Chemicalsreportable segment | depreciation | 2024-12-01 → 2025-11-30 | ¥1.1bn |
| Fine Chemicalsreportable segment | employees | at 2025-11-30 | 567 pure |
| Fine Chemicalsreportable segment | revenue | 2024-12-01 → 2025-11-30 | ¥23.3bn |
| Fine Chemicalsreportable segment | revenue external | 2024-12-01 → 2025-11-30 | ¥22.3bn |
| Fine Chemicalsreportable segment | revenue intersegment | 2024-12-01 → 2025-11-30 | ¥924m |
| Fine Chemicalsreportable segment | segment profit | 2024-12-01 → 2025-11-30 | ¥909m |
| Health And Beauty Care Foodreportable segment | depreciation | 2024-12-01 → 2025-11-30 | ¥62m |
| Health And Beauty Care Foodreportable segment | employees | at 2025-11-30 | 301 pure |
| Health And Beauty Care Foodreportable segment | revenue | 2024-12-01 → 2025-11-30 | ¥18.3bn |
| Health And Beauty Care Foodreportable segment | revenue external | 2024-12-01 → 2025-11-30 | ¥18.2bn |
| Health And Beauty Care Foodreportable segment | revenue intersegment | 2024-12-01 → 2025-11-30 | ¥76m |
| Health And Beauty Care Foodreportable segment | segment profit | 2024-12-01 → 2025-11-30 | ¥700m |
| Industrial Chemicalsreportable segment | depreciation | 2024-12-01 → 2025-11-30 | ¥325m |
| Industrial Chemicalsreportable segment | employees | at 2025-11-30 | 334 pure |
| Industrial Chemicalsreportable segment | revenue | 2024-12-01 → 2025-11-30 | ¥9.7bn |
| Industrial Chemicalsreportable segment | revenue external | 2024-12-01 → 2025-11-30 | ¥9.7bn |
| Industrial Chemicalsreportable segment | revenue intersegment | 2024-12-01 → 2025-11-30 | ¥3m |
| Industrial Chemicalsreportable segment | segment profit | 2024-12-01 → 2025-11-30 | ¥733m |
| Medicalreportable segment | depreciation | 2024-12-01 → 2025-11-30 | ¥260m |
| Medicalreportable segment | employees | at 2025-11-30 | 225 pure |
| Medicalreportable segment | revenue | 2024-12-01 → 2025-11-30 | ¥12.8bn |
| Medicalreportable segment | revenue external | 2024-12-01 → 2025-11-30 | ¥12.4bn |
| Medicalreportable segment | revenue intersegment | 2024-12-01 → 2025-11-30 | ¥321m |
| Medicalreportable segment | segment profit | 2024-12-01 → 2025-11-30 | ¥1.1bn |
| —segment total | depreciation | 2024-12-01 → 2025-11-30 | ¥1.7bn |
| —segment total | employees | at 2025-11-30 | 1427 pure |
| —segment total | revenue | 2024-12-01 → 2025-11-30 | ¥64.0bn |
| —segment total | revenue external | 2024-12-01 → 2025-11-30 | ¥62.7bn |
| —segment total | revenue intersegment | 2024-12-01 → 2025-11-30 | ¥1.3bn |
| —segment total | segment profit | 2024-12-01 → 2025-11-30 | ¥3.5bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2024-12-01 → 2025-11-30 | ¥1.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2024-12-01 → 2025-11-30 | ¥64.1bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2024-12-01 → 2025-11-30 | ¥62.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2024-12-01 → 2025-11-30 | ¥1.3bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2024-12-01 → 2025-11-30 | ¥3.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | depreciation | 2023-12-01 → 2024-11-30 | ¥3m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-12-01 → 2024-11-30 | ¥46m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-12-01 → 2024-11-30 | ¥38m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-12-01 → 2024-11-30 | ¥8m |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-12-01 → 2024-11-30 | −¥129m |
| Reconciling Itemsreconciling | depreciation | 2023-12-01 → 2024-11-30 | ¥426m |
| Reconciling Itemsreconciling | revenue | 2023-12-01 → 2024-11-30 | −¥1.4bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-12-01 → 2024-11-30 | −¥1.4bn |
| Reconciling Itemsreconciling | segment profit | 2023-12-01 → 2024-11-30 | −¥6m |
| Fine Chemicalsreportable segment | depreciation | 2023-12-01 → 2024-11-30 | ¥1.0bn |
| Fine Chemicalsreportable segment | revenue | 2023-12-01 → 2024-11-30 | ¥22.0bn |
| Fine Chemicalsreportable segment | revenue external | 2023-12-01 → 2024-11-30 | ¥21.1bn |
| Fine Chemicalsreportable segment | revenue intersegment | 2023-12-01 → 2024-11-30 | ¥912m |
| Fine Chemicalsreportable segment | segment profit | 2023-12-01 → 2024-11-30 | ¥219m |
| Health And Beauty Care Foodreportable segment | depreciation | 2023-12-01 → 2024-11-30 | ¥48m |
| Health And Beauty Care Foodreportable segment | revenue | 2023-12-01 → 2024-11-30 | ¥15.3bn |
| Health And Beauty Care Foodreportable segment | revenue external | 2023-12-01 → 2024-11-30 | ¥15.2bn |
| Health And Beauty Care Foodreportable segment | revenue intersegment | 2023-12-01 → 2024-11-30 | ¥94m |
| Health And Beauty Care Foodreportable segment | segment profit | 2023-12-01 → 2024-11-30 | ¥623m |
| Industrial Chemicalsreportable segment | depreciation | 2023-12-01 → 2024-11-30 | ¥323m |
| Industrial Chemicalsreportable segment | revenue | 2023-12-01 → 2024-11-30 | ¥10.3bn |
| Industrial Chemicalsreportable segment | revenue external | 2023-12-01 → 2024-11-30 | ¥10.2bn |
| Industrial Chemicalsreportable segment | revenue intersegment | 2023-12-01 → 2024-11-30 | ¥70m |
| Industrial Chemicalsreportable segment | segment profit | 2023-12-01 → 2024-11-30 | ¥807m |
| Medicalreportable segment | depreciation | 2023-12-01 → 2024-11-30 | ¥211m |
| Medicalreportable segment | revenue | 2023-12-01 → 2024-11-30 | ¥11.8bn |
| Medicalreportable segment | revenue external | 2023-12-01 → 2024-11-30 | ¥11.5bn |
| Medicalreportable segment | revenue intersegment | 2023-12-01 → 2024-11-30 | ¥315m |
| Medicalreportable segment | segment profit | 2023-12-01 → 2024-11-30 | ¥1.3bn |
| —segment total | depreciation | 2023-12-01 → 2024-11-30 | ¥1.6bn |
| —segment total | revenue | 2023-12-01 → 2024-11-30 | ¥59.3bn |
| —segment total | revenue external | 2023-12-01 → 2024-11-30 | ¥58.0bn |
| —segment total | revenue intersegment | 2023-12-01 → 2024-11-30 | ¥1.4bn |
| —segment total | segment profit | 2023-12-01 → 2024-11-30 | ¥3.0bn |
| Total Of Reportable Segments And Otherssegment total | depreciation | 2023-12-01 → 2024-11-30 | ¥1.6bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-12-01 → 2024-11-30 | ¥59.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-12-01 → 2024-11-30 | ¥58.0bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2023-12-01 → 2024-11-30 | ¥1.4bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-12-01 → 2024-11-30 | ¥2.8bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 1,935
| Item | Context | Value | Unit |
|---|---|---|---|
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京（０３）３２７９－０４８１ | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)財務企画部長 上山 勇 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E02585 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 80950 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)アステナホールディングス株式会社 | |
| Filer name in english | FilingDateInstant | Astena Holdings Co., Ltd. | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第三号様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Current fiscal year start date | FilingDateInstant | 2024-12-01 | |
| Current period end date | FilingDateInstant | 2025-11-30 | |
| Type of current period | FilingDateInstant | FY | |
| Current fiscal year end date | FilingDateInstant | 2025-11-30 | |
| Previous fiscal year start date | FilingDateInstant | 2023-12-01 | |
| Comparative period end date | FilingDateInstant | 2024-11-30 | |
| Previous fiscal year end date | FilingDateInstant | 2024-11-30 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Business results of reporting company (text) | FilingDateInstant | Text · Plus | |
| Company history (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Overview of affiliated entities (text) | FilingDateInstant | Text · Plus | |
| Information about employees (text) | FilingDateInstant | Text · Plus | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row1Member | Original text (Japanese)スペラファーマ株式会社 | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row2Member | Original text (Japanese)イワキ株式会社 | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row3Member | Original text (Japanese)岩城製薬株式会社 | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row4Member | Original text (Japanese)メルテックス株式会社 | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row5Member | Original text (Japanese)スペラネクサス株式会社 | |
| Consolidated subsidiaries metrics of consolidated subsidiaries | CurrentYearInstant_Row6Member | Original text (Japanese)岩城製薬佐倉工場株式会社 | |
| Business policy business environment issues to address etc (text) | FilingDateInstant | Text · Plus | |
| Disclosure of sustainability related financial information (text) | FilingDateInstant | Text · Plus | |
| Governance (text) | FilingDateInstant | Text · Plus | |
| Strategy (text) | FilingDateInstant | Text · Plus | |
| Risk management (text) | FilingDateInstant | Text · Plus | |
| Metrics and targets (text) | FilingDateInstant | Text · Plus | |
| Governance climate change (text) | FilingDateInstant | Text · Plus | |
| Strategy climate change (text) | FilingDateInstant | Text · Plus | |
| Risk management climate change (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 24 of 24 passed
| balance sheet identity | pass |
| balance sheet identity | pass rounding |
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |